PPMS Onset Upon Adalimumab Treatment Extends the Spectrum of Anti-TNF-Α Therapy-Associated Demyelinating Disorders

Therapeutic Advances in Neurological Disorders - United Kingdom
doi 10.1177/1756286419895155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications


Related search